Premium Reports
Top 20

Top 20
2005 Best in KLAS

| Read Time: Unknown

The Top 20 Year-End Best in KLAS Report is a summary of the performance data collected over the past 13 months from healthcare professionals and I.T. Executives.

Included in the report is a ranking of the Top 20 vendors overall, as well as a ranking of the top vendors in key areas of performance.

Vendors and products are broken down into 26 key market segments:

  • Acute Care CDR, Orders & Charting
  • Acute Care Reg/Sched/PA
  • Ambulatory Billing & Scheduling (Over 100 Physicians)
  • Ambulatory Billing & Scheduling (26-100 Physicians)
  • Ambulatory Billing & Scheduling (6-25 Physicians)
  • Ambulatory Billing & Scheduling (1-5 Physicians)
  • Ambulatory EMR (Over 25 Physicians)
  • Ambulatory EMR (6-25 Physicians)
  • Ambulatory EMR (1-5 Physicians)
  • Cardiology PACS
  • Cardiology Reporting & Documenting
  • Community Clinical and Ancillary Systems
  • Community HIS
  • Decision Support – Business
  • Dictation, Transcription & Speech Recognition
  • Document Management & Imaging
  • Emergency Department Systems
  • Enterprise Scheduling
  • Financial/ERP
  • Home Health
  • Laboratory
  • PACS
  • Pharmacy
  • Radiology
  • Surgery Management
  • Specialty Niche

For the first year, Professional Services Firms are broken down into six areas:

  • Clinical Implementation Principal
  • Clinical Implementation Supportive
  • Financial Implementation Principal
  • Full IT Outsourcing
  • Planning & Assessment
  • Technical Consulting

Want to see full details?

 Download Report Brief  Download Full Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2018 KLAS Enterprises, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.